All Stories

  1. Feasibility of Point-of-Care Testing for Influenza Within a National Primary Care Sentinel Surveillance Network in England: Protocol for a Mixed Methods Study

    Article • JMIR Research Protocols, November 2019, JMIR Publications Inc.

    Dr Javier Diez-Domingo

  2. ¿Qué hemos aprendido sobre rotavirus en España en los últimos 10 años?

    Article • Anales de Pediatría, September 2019, Elsevier

    Dr Javier Diez-Domingo

  3. Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

    Article • Human Vaccines & Immunotherapeutics, June 2019, Taylor & Francis

    Professor Anthony L Cunningham, Dr Javier Diez-Domingo

  4. Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network

    Article • BMC Infectious Diseases, May 2019, Springer Science + Business Media

    Dr Javier Diez-Domingo

  5. Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)

    Article • BMC Public Health, May 2019, Springer Science + Business Media

    Dr Javier Diez-Domingo

  6. Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

    Article • Vaccine, April 2019, Elsevier

    Dr Javier Diez-Domingo

  7. Feasibility of Point-of-Care Testing for Influenza Within a National Primary Care Sentinel Surveillance Network in England: Protocol for a Mixed Methods Study (Preprint)

    Article • March 2019, JMIR Publications Inc.

    Dr Javier Diez-Domingo

  8. Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study

    Article • Journal of the Pediatric Infectious Diseases Society, March 2019, Oxford University Press (OUP)

    Dr Javier Diez-Domingo

  9. Letter to the editor regarding “Rotavirus infection beyond the gut”

    Article • Infection and Drug Resistance, March 2019, Dove Medical Press

    Dr Javier Diez-Domingo

  10. Rapid assessment of enhanced safety surveillance for influenza vaccine

    Article • Public Health, March 2019, Elsevier

    Dr Javier Diez-Domingo

  11. Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6–35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres

    Article • Vaccine, December 2018, Elsevier

    Dr Javier Diez-Domingo

  12. Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers

    Article • The Pediatric Infectious Disease Journal, November 2018, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  13. Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study

    Article • PLoS ONE, October 2018, PLOS

    Dr Javier Diez-Domingo

  14. Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children

    Article • The Pediatric Infectious Disease Journal, October 2018, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  15. Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines – Multi-country assessment

    Article • Vaccine, October 2018, Elsevier

    Dr Javier Diez-Domingo, Dr. Hsi-Chung Chen

  16. Impact of postherpetic neuralgia: A six year population-based analysis on people aged 50 years or older

    Article • Journal of Infection, August 2018, Elsevier

    Dr Javier Diez-Domingo

  17. Influence of health literacy on acceptance of influenza and pertussis vaccinations: a cross-sectional study among Spanish pregnant women

    Article • BMJ Open, July 2018, BMJ

    Dr Enrique Castro-Sánchez, Dr Javier Diez-Domingo

  18. Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older

    Article • The Journals of Gerontology Series A, June 2018, Oxford University Press (OUP)

    Dr Javier Diez-Domingo

  19. Clinical and laboratory features of children with community-acquired pneumonia are associated with distinct radiographic presentations

    Article • European Journal of Pediatrics, May 2018, Springer Science + Business Media

    Dr Javier Diez-Domingo

  20. Risk and impact of herpes zoster among COPD patients: a population-based study, 2009–2014

    Article • BMC Infectious Diseases, May 2018, Springer Science + Business Media

    Dr Javier Diez-Domingo

  21. Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons

    Article • The Lancet Child & Adolescent Health, May 2018, Elsevier

    Dr Javier Diez-Domingo

  22. Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17

    Article • Eurosurveillance, February 2018, European Centre for Disease Control and Prevention (ECDC)

    Dr Javier Diez-Domingo

  23. Lack of impact of rotavirus vaccines on seizure-related hospitalizations in children under 5 years old in Spain

    Article • Human Vaccines & Immunotherapeutics, February 2018, Taylor & Francis

    Dr Javier Diez-Domingo

  24. Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative

    Article • Vaccine, January 2018, Elsevier

    Dr Javier Diez-Domingo

  25. Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination

    Article • Vaccine, January 2018, Elsevier

    Dr Javier Diez-Domingo

  26. Letter to the Editor regarding “The role of age-sex interaction in the development of post-herpetic neuralgia”

    Article • Human Vaccines & Immunotherapeutics, December 2017, Taylor & Francis

    Dr Javier Diez-Domingo

  27. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season

    Article • Vaccine, December 2017, Elsevier

    Dr Javier Diez-Domingo

  28. Random Network Models to Predict the Long-Term Impact of HPV Vaccination on Genital Warts

    Article • Viruses, October 2017, MDPI AG

    Dr Javier Diez-Domingo

  29. Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules

    Article • Canadian Medical Association Journal, October 2017, Canadian Medical Association (CMA)

    Dr Javier Diez-Domingo

  30. Economic Burden Of Herpes Zoster In Spain

    Article • Value in Health, October 2017, Elsevier

    Dr Javier Diez-Domingo

  31. Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015

    Article • Vaccine, October 2017, Elsevier

    Dr Javier Diez-Domingo

  32. Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009–2014

    Article • Human Vaccines & Immunotherapeutics, September 2017, Taylor & Francis

    Dr Javier Diez-Domingo

  33. Random network models to predict the long term impact of HPV vaccination on genital warts

    Article • July 2017, MDPI AG

    Dr Javier Diez-Domingo

  34. Drivers for human papillomavirus vaccination in Valencia (Spain)

    Article • Gaceta Sanitaria, July 2017, Elsevier

    Dr Javier Diez-Domingo

  35. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain

    Article • Vaccine, June 2017, Elsevier

    Dr Javier Diez-Domingo

  36. Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination

    Article • Vaccine, May 2017, Elsevier

    Dr Javier Diez-Domingo

  37. Corrigendum to “Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial” [Vaccine 3...

    Article • Vaccine, May 2017, Elsevier

    Dr Javier Diez-Domingo

  38. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain

    Article • BMC Infectious Diseases, April 2017, Springer Science + Business Media

    Dr Javier Diez-Domingo

  39. Antibiotic Use in Children – A Cross-National Analysis of 6 Countries

    Article • The Journal of Pediatrics, March 2017, Elsevier

    Dr Javier Diez-Domingo

  40. Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial

    Article • Vaccine, January 2017, Elsevier

    Dr Javier Diez-Domingo

  41. Infecciones por virus respiratorio sincitial en adultos diagnosticados en la Comunidad Valenciana

    Article • Revista Clínica Española, December 2016, Elsevier

    Dr Javier Diez-Domingo

  42. Determinants of seasonal influenza vaccination in pregnant women in Valencia, Spain

    Article • BMC Public Health, November 2016, Springer Science + Business Media

    Dr Javier Diez-Domingo, Dr Enrique Castro-Sánchez

  43. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season

    Article • Journal of Clinical Virology, November 2016, Elsevier

    Dr Javier Diez-Domingo

  44. Rotavirus, vaccine failure or diagnostic error?

    Article • Vaccine, November 2016, Elsevier

    Dr Javier Diez-Domingo

  45. Herpes Zoster-Associated Resources Consumption In Chronic Obstructive Pulmonary Disease Patients

    Article • Value in Health, November 2016, Elsevier

    Dr Javier Diez-Domingo

  46. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, September 2016, New England Journal of Medicine (NEJM/MMS)

    Dr Javier Diez-Domingo

  47. Safety and tolerability of cell culture-derived and egg-derived trivalent influenza vaccines in 3 to <18-year-old children and adolescents at risk of influenza-related complications

    Article • International Journal of Infectious Diseases, August 2016, Elsevier

    Dr Javier Diez-Domingo

  48. Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination system

    Article • Public Health, June 2016, Elsevier

    Dr Javier Diez-Domingo

  49. Comparison between diagnosis and treatment of community-acquired pneumonia in children in various medical centres across Europe with the United States, United Kingdom and the World Health Organization guidelines

    Article • Pneumonia, May 2016, Springer Science + Business Media

    Dr Javier Diez-Domingo

  50. Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age

    Article • The Pediatric Infectious Disease Journal, April 2016, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  51. Population-based Analysis of Bronchiolitis Epidemiology in Valencia, Spain

    Article • The Pediatric Infectious Disease Journal, March 2016, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  52. Studying the Herd Immunity Effect of the Varicella Vaccine in the Community of Valencia, Spain

    Article • January 2016, Springer Science + Business Media

    Dr Javier Diez-Domingo

  53. Vacuna triple vírica. Resurgimiento del sarampión en Europa

    Article • Enfermedades Infecciosas y Microbiología Clínica, December 2015, Elsevier

    Dr Javier Diez-Domingo

  54. Aceptabilidad de la vacuna contra el virus del papiloma humano en madres de la provincia de Valencia (España)

    Article • Anales de Pediatría, November 2015, Elsevier

    Dr Javier Diez-Domingo

  55. A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls

    Article • The Pediatric Infectious Disease Journal, September 2015, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  56. Intussusception following rotavirus vaccination in the Valencia Region, Spain

    Article • Human Vaccines & Immunotherapeutics, June 2015, Taylor & Francis

    Dr Javier Diez-Domingo

  57. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2015, New England Journal of Medicine (NEJM/MMS)

    Dr Javier Diez-Domingo

  58. Vaccine coverage estimation using a computerized vaccination registry with potential underreporting and a seroprevalence study

    Article • Vaccine, April 2015, Elsevier

    Dr Javier Diez-Domingo

  59. Rotavirus vaccine effectiveness in a large cohort

    Article • BMC Infectious Diseases, February 2015, Springer Science + Business Media

    Dr Javier Diez-Domingo, Mr Miguel A Martinez-Beneito

  60. Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination

    Article • Influenza and Other Respiratory Viruses, February 2015, Wiley

    Dr Javier Diez-Domingo

  61. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: A randomised non-inferiority clinical trial

    Article • Vaccine, February 2015, Elsevier

    Dr Javier Diez-Domingo

  62. Vacunación frente a la hepatitisB. Impacto de los programas de vacunación tras 20años de su utilización en España. ¿Es tiempo de cambios?

    Article • Enfermedades Infecciosas y Microbiología Clínica, February 2015, Elsevier

    Dr Javier Diez-Domingo

  63. Influenza Vaccine Effectiveness in Preventing Influenza A(H3N2)-Related Hospitalizations in Adults Targeted for Vaccination by Type of Vaccine: A Hospital-Based Test-Negative Study, 2011–2012 A(H3N2) Predominant Influenza Season, Valencia, Spain

    Article • PLoS ONE, November 2014, PLOS

    Dr Javier Diez-Domingo, Dr Alberto Arnedo-Pena

  64. Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007–2011)

    Article • Anales de Pediatría (English Edition), November 2014, Elsevier

    Dr Javier Diez-Domingo

  65. Notificación de reacciones adversas a la vacuna frente al virus del papiloma humano en la Comunidad Valenciana (2007-2011)

    Article • Anales de Pediatría, November 2014, Elsevier

    Dr Javier Diez-Domingo

  66. Social, economic, and health impact of the respiratory syncytial virus: a systematic search

    Article • BMC Infectious Diseases, October 2014, Springer Science + Business Media

    Dr Javier Diez-Domingo

  67. Seroprevalencia frente a sarampión, rubeola y parotiditis en personal facultativo del servicio de pediatría del Hospital Universitario y Politécnico La Fe de Valencia

    Article • Revista Española de Salud Pública, October 2014, Instituto de Salud Carlos III/BNCS/SciELO Espana

    Dr Javier Diez-Domingo

  68. Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011–2012 influenza season: A comparative effectiveness study using the Valencia health care information system

    Article • Vaccine, September 2014, Elsevier

    Dr Javier Diez-Domingo

  69. A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants

    Article • Vaccine, September 2014, Elsevier

    Dr Javier Diez-Domingo

  70. Vigilancia pasiva de la seguridad postautorización de las vacunas frente a rotavirus: sensibilidad de la notificación de invaginación intestinal

    Article • Anales de Pediatría, August 2014, Elsevier

    Dr Javier Diez-Domingo

  71. Post-licensure passive safety surveillance of rotavirus vaccines: Reporting sensitivity for intussusception

    Article • Anales de Pediatría (English Edition), August 2014, Elsevier

    Dr Javier Diez-Domingo

  72. Author's Response Re: Letter to the Editor Re: Martínez-García R, Úbeda-Sansano MI, Díez-Domingo J, Pérez-Hoyos S, Gil-Salom M. It is time to abandon “expected bladder capacity.” Systematic review and new models for children's normal maximum voided volume

    Article • Neurourology and Urodynamics, June 2014, Wiley

    Dr Javier Diez-Domingo

  73. “Knowledge and attitudes of Spanish adolescent girls towards human papillomavirus infection: where to intervene to improve vaccination coverage”

    Article • BMC Public Health, May 2014, Springer Science + Business Media

    Dr Javier Diez-Domingo

  74. Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)

    Article • BMC Infectious Diseases, May 2014, Springer Science + Business Media

    Dr Javier Diez-Domingo, Dr Raquel Abad

  75. Re: Martínez-García R, Ubeda-Sansano MI, Díez-Domingo J, Pérez-Hoyos S, Gil-Salom M. It is time to abandon “Expected bladder capacity.” Systematic review and new models for children's normal maximum voided volumes. Neurourol Urodyn 2014;33:1092-8

    Article • Neurourology and Urodynamics, May 2014, Wiley

    Dr Javier Diez-Domingo

  76. Ethical considerations of universal vaccination against human papilloma virus

    Article • BMC Medical Ethics, April 2014, Springer Science + Business Media

    Dr Javier Diez-Domingo

  77. Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10–17 years of age: Results from a randomised, controlled, double-blind trial

    Article • Vaccine, December 2013, Elsevier

    Dr Javier Diez-Domingo

  78. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain

    Article • Vaccine, November 2013, Elsevier

    Dr Javier Diez-Domingo

  79. Herpes zoster surveillance using electronic databases in the Valencian Community (Spain)

    Article • BMC Infectious Diseases, October 2013, Springer Science + Business Media

    Dr Javier Diez-Domingo

  80. Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule

    Article • Vaccine, October 2013, Elsevier

    Dr Javier Diez-Domingo

  81. Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population

    Article • The Journal of Infectious Diseases, September 2013, Oxford University Press (OUP)

    Dr Javier Diez-Domingo

  82. A clinical study of a shingles (Herpes Zoster) vaccine (Live) administered by intramuscular or subcutaneous routes in adults aged≥50 years

    Article • European Geriatric Medicine, September 2013, Elsevier

    Dr Javier Diez-Domingo

  83. MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: Comparative effectiveness using the Valencia health care information system

    Article • Vaccine, August 2013, Elsevier

    Dr Javier Diez-Domingo

  84. It is time to abandon “Expected bladder capacity.” Systematic review and new models for children's normal maximum voided volumes

    Article • Neurourology and Urodynamics, July 2013, Wiley

    Dr Javier Diez-Domingo

  85. Sospecha de reacciones adversas a la vacuna triple vírica notificadas al Centro de Farmacovigilancia de la Comunidad Valenciana

    Article • Anales de Pediatría, May 2013, Elsevier

    Dr Javier Diez-Domingo

  86. Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea

    Article • Human Vaccines & Immunotherapeutics, March 2013, Taylor & Francis

    Dr Javier Diez-Domingo

  87. Gut Microbiota in Children Vaccinated With Rotavirus Vaccine

    Article • The Pediatric Infectious Disease Journal, December 2012, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  88. Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine Manufactured With Recombinant Human Albumin

    Article • The Pediatric Infectious Disease Journal, November 2012, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  89. Effectiveness of the 2010–2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case–case comparison, case-control study

    Article • Vaccine, August 2012, Elsevier

    Dr Javier Diez-Domingo

  90. Antibiotic Therapy for Pediatric Community-acquired Pneumonia

    Article • The Pediatric Infectious Disease Journal, June 2012, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  91. The impact of childhood acute rotavirus gastroenteritis on the parents’ quality of life: prospective observational study in European primary care medical practices

    Article • BMC Pediatrics, May 2012, Springer Science + Business Media

    Dr Javier Diez-Domingo

  92. 13-valent Pneumococcal Conjugate Vaccine Given With Meningococcal C–Tetanus Toxoid Conjugate and Other Routine Pediatric Vaccinations

    Article • The Pediatric Infectious Disease Journal, April 2012, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  93. Immunogenicity and Tolerability of Recombinant Serogroup B Meningococcal Vaccine Administered With or Without Routine Infant Vaccinations According to Different Immunization Schedules

    Article • JAMA, February 2012, American Medical Association (AMA)

    Professor Adam Finn, Dr Javier Diez-Domingo

  94. Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain)

    Article • Vaccine, December 2011, Elsevier

    Dr Javier Diez-Domingo

  95. MF59™-adjuvanted seasonal influenza vaccine in young children

    Article • Expert Review of Vaccines, November 2011, Taylor & Francis

    Dr Javier Diez-Domingo

  96. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the valencian community of Spain

    Article • BMC Infectious Diseases, November 2011, Springer Science + Business Media

    Dr Javier Diez-Domingo

  97. Using random networks to study the dynamics of respiratory syncytial virus (RSV) in the Spanish region of Valencia

    Article • Mathematical and Computer Modelling, October 2011, Elsevier

    Dr Javier Diez-Domingo

  98. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conj...

    Article • Vaccine, August 2011, Elsevier

    Dr Javier Diez-Domingo

  99. Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain

    Article • Human Vaccines, July 2011, Taylor & Francis

    Dr Javier Diez-Domingo

  100. Evidencias científicas disponibles sobre la seguridad de las vacunas

    Article • Vacunas, January 2011, Elsevier

    Dr Javier Diez-Domingo

  101. Cost analysis of a vaccination strategy for respiratory syncytial virus (RSV) in a network model

    Article • Mathematical and Computer Modelling, October 2010, Elsevier

    Dr Javier Diez-Domingo

  102. A RANDOMIZED, MULTICENTER, OPEN-LABEL CLINICAL TRIAL TO ASSESS THE ANAMNESTIC IMMUNE RESPONSE 4 TO 8 YEARS AFTER A PRIMARY HEPATITIS B VACCINATION SERIES

    Article • The Pediatric Infectious Disease Journal, October 2010, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  103. Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countries

    Article • European Journal of Pediatrics, September 2010, Springer Science + Business Media

    Dr Javier Diez-Domingo

  104. Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain

    Article • BMC Public Health, August 2010, Springer Science + Business Media

    Dr Javier Diez-Domingo

  105. ANTIBODY PERSISTENCE 12 MONTHS AFTER A BOOSTER DOSE OF MENINGOCOCCAL-C CONJUGATED VACCINE IN THE SECOND YEAR OF LIFE

    Article • The Pediatric Infectious Disease Journal, August 2010, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  106. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes

    Article • Clinical Microbiology and Infection, July 2010, Elsevier

    Dr Javier Diez-Domingo

  107. Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1–11 years

    Article • Vaccine, June 2010, Elsevier

    Dr Javier Diez-Domingo

  108. Epidemiology of Herpes Zoster Infection among Patients Treated in Primary Care Centres in the Valencian Community (Spain)

    Article • BMC Family Practice, May 2010, Springer Science + Business Media

    Dr Javier Diez-Domingo

  109. Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-Adjuvanted Prepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years

    Article • The Pediatric Infectious Disease Journal, March 2010, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  110. Invasive Haemophilus influenzae Disease, Europe, 1996–2006

    Article • Emerging Infectious Diseases, March 2010, Centers for Disease Control and Prevention (CDC)

    Dr Javier Diez-Domingo

  111. Palatabilidad de las soluciones de rehidratación oral en niños sanos de 6 a 9 años. Ensayo clínico multicéntrico, aleatorizado y simple ciego

    Article • Anales de Pediatría, February 2010, Elsevier

    Dr Javier Diez-Domingo

  112. A Randomized, Multicenter, Open-Label Clinical Trial to Assess the Immunogenicity of a Meningococcal C Vaccine Booster Dose Administered to Children Aged 14 to 18 Months

    Article • The Pediatric Infectious Disease Journal, February 2010, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  113. Nosocomial Rotavirus Gastroenteritis in Spain

    Article • The Pediatric Infectious Disease Journal, January 2010, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  114. Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications

    Article • Epidemiology and Infection, December 2009, Cambridge University Press

    Dr Javier Diez-Domingo

  115. PIN17 THE COST OF ROTAVIRUS GASTROENTERITIS IN YOUNG CHILDREN IN FOUR EUROPEAN COUNTRIES: A STUDY IN PRIMARY CARE

    Article • Value in Health, October 2009, Elsevier

    Dr Javier Diez-Domingo

  116. Calendario vacunal de la Asociación Española de Pediatría 2009

    Article • Vacunas, July 2009, Elsevier

    Dr Javier Diez-Domingo

  117. Calendario vacunal de la Asociación Española de Pediatría: Recomendaciones 2009

    Article • Anales de Pediatría, January 2009, Elsevier

    Dr Javier Diez-Domingo

  118. Pertussis in adults with persistent cough: a prospective follow up study in primary care

    Article • Procedia in Vaccinology, January 2009, Elsevier

    Dr Javier Diez-Domingo

  119. Pediatric Safety Evaluation of An AS-Adjuvanted H5N1 Prepandemic Candidate Vaccine in Children Aged 3–9 Years: A Phase II Study

    Article • International Journal of Infectious Diseases, December 2008, Elsevier

    Dr Javier Diez-Domingo

  120. Recomendaciones de vacunación de la Asociación Española de Pediatría 2008

    Article • Vacunas, April 2008, Elsevier

    Dr Javier Diez-Domingo

  121. ¿Por qué hay más empiemas pediátricos en España?

    Article • Anales de Pediatría, February 2008, Elsevier

    Dr Javier Diez-Domingo

  122. Criterios de inclusión de vacunas en el calendario de la Asociación Española de Pediatría

    Article • Anales de Pediatría, January 2008, Elsevier

    Dr Javier Diez-Domingo

  123. Calendario vacunal de la Asociación Española de Pediatría: recomendaciones 2008

    Article • Anales de Pediatría, January 2008, Elsevier

    Dr Javier Diez-Domingo

  124. Effectiveness of MF59™-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly

    Article • Vaccine, October 2007, Elsevier

    Dr Javier Diez-Domingo

  125. Dos vacunas frente a rotavirus seguras y eficaces

    Article • Anales de Pediatría, February 2007, Elsevier

    Dr Javier Diez-Domingo

  126. Rotavirus vaccines: considerations for successful implementation in Europe

    Article • The Lancet Infectious Diseases, December 2006, Elsevier

    Dr Javier Diez-Domingo

  127. Article • Anales de Pediatría, December 2006, Elsevier

    Dr Javier Diez-Domingo

  128. Economic evaluation of varicella vaccination in Spain—Results from a dynamic model

    Article • Vaccine, November 2006, Elsevier

    Dr Javier Diez-Domingo

  129. Vacuna frente al virus del papiloma humano: un nuevo reto para el pediatra

    Article • Anales de Pediatría, November 2006, Elsevier

    Dr Javier Diez-Domingo

  130. Incidencia y costes de la hospitalización por bronquiolitis y de las infecciones por virus respiratorio sincitial en la Comunidad Valenciana. Años 2001 y 2002

    Article • Anales de Pediatría, October 2006, Elsevier

    Dr Javier Diez-Domingo

  131. Estudio de costes directos de la otitis media aguda en menores de 5 años en la Comunidad Valenciana

    Article • Vacunas, July 2006, Elsevier

    Dr Javier Diez-Domingo

  132. Gripe aviar: ¿para cuándo la vacuna?

    Article • Medicina Clínica, June 2006, Elsevier

    Dr Javier Diez-Domingo

  133. ROTAVIRUS GASTROENTERITIS AMONG CHILDREN UNDER FIVE YEARS OF AGE IN VALENCIA, SPAIN

    Article • The Pediatric Infectious Disease Journal, May 2006, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  134. Calendario de vacunación de la Asociación Española de Pediatría: recomendaciones 2006

    Article • Anales de Pediatría, January 2006, Elsevier

    Dr Javier Diez-Domingo

  135. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1–11-year-old children

    Article • Vaccine, October 2005, Elsevier

    Dr Javier Diez-Domingo

  136. Seroprevalence of Varicella Among Children and Adolescents in Valencia, Spain: Reliability of the Parent’s Reported History and the Medical File for Identification of Potential Candidates for Vaccination

    Article • Human Vaccines, September 2005, Taylor & Francis

    Dr Javier Diez-Domingo

  137. Epidemiología de la neumonía adquirida en la comunidad en menores de 5 años en la Comunidad Valenciana

    Article • Anales de Pediatría, August 2005, Elsevier

    Dr Javier Diez-Domingo

  138. Immunogenicity and Reactogenicity of a Combined Adsorbed Tetanus Toxoid, Low Dose Diphtheria Toxoid, Five Component Acellular Pertussis and Inactivated Polio Vaccine in Six-Year-Old Children

    Article • The Pediatric Infectious Disease Journal, March 2005, Wolters Kluwer Health

    Dr Javier Diez-Domingo

  139. Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age

    Article • Vaccine, December 2004, Elsevier

    Dr Javier Diez-Domingo

  140. Investigación en pediatría de atención primaria: la asignatura pendiente

    Article • Anales de Pediatría, October 2004, Elsevier

    Dr Javier Diez-Domingo

  141. Incidence of pertussis in persons ≤15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults

    Article • Journal of Infection, October 2004, Elsevier

    Dr Javier Diez-Domingo

  142. Risk factors for invasive disease among children in Spain

    Article • Journal of Infection, May 2004, Elsevier

    Dr Javier Diez-Domingo

  143. Epidemiología e impacto de la otitis media aguda en la Comunidad Valenciana

    Article • Anales de Pediatría, February 2004, Elsevier

    Dr Javier Diez-Domingo

  144. Investigación en pediatría de atención primaria: la asignatura pendiente

    Article • Anales de Pediatría, January 2004, Elsevier

    Dr Javier Diez-Domingo

  145. Epidemiología e impacto de la otitis media aguda en la Comunidad Valenciana

    Article • Anales de Pediatría, January 2004, Elsevier

    Dr Javier Diez-Domingo

  146. Epidemiology and economic impact of varicella in immunocompetent children in Spain.

    Article • Vaccine, July 2003, Elsevier

    Dr Javier Diez-Domingo

  147. Atención a neonatos en una unidad de urgencias pediátricas

    Article • Anales de Pediatría, July 2003, Elsevier

    Dr Javier Diez-Domingo

  148. Inmunización: saltos al futuro. Vacunas combinadas (II)

    Article • Atención Primaria, May 2003, Elsevier

    Dr Javier Diez-Domingo

  149. Sistemas de información en atención primaria: ¿debemos codificar con la CIE-9-MC?

    Article • Atención Primaria, May 2003, Elsevier

    Dr Javier Diez-Domingo

  150. Inmunización: saltos al futuro. Vacunas combinadas (I)

    Article • Atención Primaria, April 2003, Elsevier

    Dr Javier Diez-Domingo

  151. Vacunas combinadas (I)

    Article • Atención Primaria, January 2003, Elsevier

    Dr Javier Diez-Domingo

  152. Vacunas combinadas (II)

    Article • Atención Primaria, January 2003, Elsevier

    Dr Javier Diez-Domingo

  153. Vacuna del meningococo, ¿necesidad de revacunaciones?

    Article • Anales de Pediatría Continuada, January 2003, Elsevier

    Dr Javier Diez-Domingo

  154. Sistemas de información en atención primaria: ¿debemos codificar con la CIE-9-MC?

    Article • Atención Primaria, January 2003, Elsevier

    Dr Javier Diez-Domingo

  155. Evolución de la enfermedad invasiva por Haemophilus influenzae tipo b en niños de la Comunidad Valenciana y su relación con las vacunas combinadas

    Article • Vacunas, January 2003, Elsevier

    Dr Javier Diez-Domingo

  156. Encuesta sobre el uso racional de antibióticos en atención primaria

    Article • Anales de Pediatría, January 2003, Elsevier

    Dr Javier Diez-Domingo

  157. Encuesta sobre el uso racional de antibióticos en atención primaria

    Article • Anales de Pediatría, January 2003, Elsevier

    Dr Javier Diez-Domingo

  158. Epidemiology of Invasive Streptococcus pneumoniae Infections in Children in Spain, 1996–1998

    Article • Journal of Infection, October 2002, Elsevier

    Dr Javier Diez-Domingo

  159. Encefalitis centroeuropea o transmitida por garrapatas

    Article • Vacunas, January 2002, Elsevier

    Dr Javier Diez-Domingo

  160. Efectos adversos tras la vacunación con dos vacunas de polisacárido de meningococo C conjugado con CRM197, en niños de 1 a 6 años de edad. Ensayo clínico controlado

    Article • Vacunas, January 2002, Elsevier

    Dr Javier Diez-Domingo

  161. Impact of Non-routine Vaccination on the Incidence of Invasive Haemophilus influenzae Type b (Hib) Disease: Experience in the Autonomous Region of Valencia, Spain

    Article • Journal of Infection, July 2001, Elsevier

    Dr Javier Diez-Domingo

  162. Utilización de la alternancia de antipiréticos en el tratamiento de la fiebre en España

    Article • Anales de Pediatría, January 2001, Elsevier

    Dr Javier Diez-Domingo

  163. Epidemiological Pattern of Meningococcal Disease in Valencia, Spain. Impact of a Mass Immunization Campaign With Meningococcal C Polysaccharide Vaccine

    Article • Scandinavian Journal of Infectious Diseases, January 2001, Taylor & Francis

    Dr Javier Diez-Domingo

  164. Evaluación de la eficacia antipirética y seguridad de dos formulaciones pediátricas de ibuprofeno

    Article • Anales de Pediatría, January 2000, Elsevier

    Dr Javier Diez-Domingo

  165. A cost benefit analysis of routine varicella vaccination in Spain

    Article • Vaccine, March 1999, Elsevier

    Dr Javier Diez-Domingo

  166. Ibuprofen prophylaxis for adverse reactions to diphtheria-tetanus-pertussis vaccination: a randomized trial

    Article • Current Therapeutic Research, August 1998, Elsevier

    Dr Javier Diez-Domingo

  167. Depression in women suffering perinatal loss

    Article • International Journal of Gynecology & Obstetrics, August 1998, Wiley

    Dr Javier Diez-Domingo

  168. Adverse Events after Polysaccharide meningococcal A&C Vaccine

    Article • Scandinavian Journal of Infectious Diseases, January 1998, Taylor & Francis

    Dr Javier Diez-Domingo

  169. Prenatal deficiency of phosphate, phosphate supplementation, and rickets in very-low-birthweight infants

    Article • The Lancet, March 1990, Elsevier

    Dr Javier Diez-Domingo